Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Dai CY"" wg kryterium: Autor


Tytuł:
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan.
Autorzy:
Hsieh MH; Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; School of Medicine, Graduate Institute of Clinical Medicine, College of Medicine, Lipid Science and Aging Research Center, Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Yeh ML; School of Medicine, Graduate Institute of Clinical Medicine, College of Medicine, Lipid Science and Aging Research Center, Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Su TH; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu TW; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Huang CF; School of Medicine, Graduate Institute of Clinical Medicine, College of Medicine, Lipid Science and Aging Research Center, Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Huang CI; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Wang SC; Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; School of Medicine, Graduate Institute of Clinical Medicine, College of Medicine, Lipid Science and Aging Research Center, Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; School of Medicine, Graduate Institute of Clinical Medicine, College of Medicine, Lipid Science and Aging Research Center, Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Dai CY; Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; School of Medicine, Graduate Institute of Clinical Medicine, College of Medicine, Lipid Science and Aging Research Center, Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Kao JH; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chuang WL; School of Medicine, Graduate Institute of Clinical Medicine, College of Medicine, Lipid Science and Aging Research Center, Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Chen PJ; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Yu ML; School of Medicine, Graduate Institute of Clinical Medicine, College of Medicine, Lipid Science and Aging Research Center, Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan; Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: .
Pokaż więcej
Źródło:
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2018 Jun; Vol. 117 (6), pp. 497-504. Date of Electronic Publication: 2017 Jul 08.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B/*drug therapy
Hepatitis C/*drug therapy
Interferon-alpha/*administration & dosage
Polyethylene Glycols/*administration & dosage
Proline/*analogs & derivatives
Ribavirin/*administration & dosage
Adult ; Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Female ; Hepacivirus/genetics ; Hepatitis B/complications ; Hepatitis B virus/genetics ; Hepatitis C/complications ; Humans ; Interferon alpha-2 ; Interferon-alpha/adverse effects ; Male ; Middle Aged ; Pilot Projects ; Polyethylene Glycols/adverse effects ; Proline/administration & dosage ; Proline/adverse effects ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/adverse effects ; Recurrence ; Ribavirin/adverse effects ; Sustained Virologic Response ; Taiwan ; Viral Load ; Young Adult
Czasopismo naukowe
Tytuł:
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort.
Autorzy:
Liu TW; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Tsai PC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Huang CI; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Tsai YS; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Wang SC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Ko YM; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Lin CC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Chen KY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Liang PC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Lin YH; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hsieh MY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hou NJ; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ZY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan. Electronic address: .
Pokaż więcej
Źródło:
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2018 Jan; Vol. 117 (1), pp. 54-62. Date of Electronic Publication: 2017 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Hepatitis C, Chronic/*economics
Interferon-alpha/*therapeutic use
Ribavirin/*therapeutic use
Adult ; Aged ; Cohort Studies ; Cost-Benefit Analysis ; Drug Therapy, Combination ; Female ; Hepacivirus/genetics ; Humans ; Male ; Middle Aged ; Sustained Virologic Response ; Taiwan ; Viral Load
Czasopismo naukowe
Tytuł:
The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C.
Autorzy:
Liang PC; Graduate Institute of Clinical Medicine College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin PC; Division of Hematology and Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Special Hematologic Disease Service Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Huang CI; Graduate Institute of Clinical Medicine College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Occupational Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Zeng YS; Division of Hematology and Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Special Hematologic Disease Service Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hsu WY; Division of Hematology and Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Special Hematologic Disease Service Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hsieh MY; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ZY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Center for Infectious Disease and Cancer Research and Lipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Occupational Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Center for Infectious Disease and Cancer Research and Lipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chiou SS; Graduate Institute of Clinical Medicine College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Division of Hematology and Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Special Hematologic Disease Service Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Electronic address: .
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Center for Infectious Disease and Cancer Research and Lipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Institute of Biomedical Sciences, National Sun Yat-Sen University, Taiwan; Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: .
Pokaż więcej
Źródło:
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2018 Jan; Vol. 117 (1), pp. 14-23. Date of Electronic Publication: 2017 Oct 31.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Antiviral Agents/*therapeutic use
Blood Transfusion/*statistics & numerical data
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Ribavirin/*therapeutic use
Thalassemia/*complications
Adolescent ; Adult ; Case-Control Studies ; Drug Therapy, Combination ; Female ; Hepacivirus/genetics ; Humans ; Interferons ; Interleukins/genetics ; Logistic Models ; Male ; Middle Aged ; Retrospective Studies ; Sustained Virologic Response ; Taiwan ; Viral Load ; Young Adult
Czasopismo naukowe
Tytuł:
Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection.
Autorzy:
Lin TY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, and Center for Lipid and Glycomedicine Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CI; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan.
Chen YL; Division of General Surgery, Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, and Center for Lipid and Glycomedicine Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Occupational Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, and Center for Lipid and Glycomedicine Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ZY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, and Center for Lipid and Glycomedicine Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, and Center for Lipid and Glycomedicine Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, and Center for Lipid and Glycomedicine Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Occupational Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: .
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, and Center for Lipid and Glycomedicine Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, School of Medicine, College of Medicine, and Center for Lipid and Glycomedicine Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
The Kaohsiung journal of medical sciences [Kaohsiung J Med Sci] 2017 Jun; Vol. 33 (6), pp. 284-289. Date of Electronic Publication: 2017 Apr 20.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*administration & dosage
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*administration & dosage
Polyethylene Glycols/*administration & dosage
Ribavirin/*administration & dosage
Aged ; Drug Therapy, Combination ; Female ; Hepatitis C, Chronic/surgery ; Humans ; Liver Transplantation ; Male ; Middle Aged ; Recombinant Proteins/administration & dosage ; Recurrence ; Secondary Prevention ; Transplant Recipients ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan.
Autorzy:
Tsai PC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Liu TW; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MH; Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Liang PC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin YH; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CI; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hou NJ; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ZY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: .
Pokaż więcej
Źródło:
The Kaohsiung journal of medical sciences [Kaohsiung J Med Sci] 2017 Jan; Vol. 33 (1), pp. 44-49. Date of Electronic Publication: 2016 Nov 18.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*economics
Cost-Benefit Analysis/*statistics & numerical data
Hepatitis C, Chronic/*economics
Insurance, Health, Reimbursement/*statistics & numerical data
Interferon-alpha/*economics
Polyethylene Glycols/*economics
Ribavirin/*economics
Aged ; Antiviral Agents/therapeutic use ; Cohort Studies ; Decision Making ; Drug Therapy, Combination ; Female ; Genotype ; Hepacivirus/drug effects ; Hepacivirus/physiology ; Hepatitis C, Chronic/drug therapy ; Hepatitis C, Chronic/pathology ; Hepatitis C, Chronic/virology ; Humans ; Interferon-alpha/therapeutic use ; Male ; Middle Aged ; Polyethylene Glycols/therapeutic use ; Recombinant Proteins/economics ; Recombinant Proteins/therapeutic use ; Ribavirin/therapeutic use ; Taiwan ; Treatment Outcome ; Viral Load/drug effects
Czasopismo naukowe
Tytuł:
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection.
Autorzy:
Yeh ML; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Huang CI; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Occupational Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MH; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Center for Lipid Science and Aging Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Center for Lipid Science and Aging Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2016 Apr; Vol. 31 (4), pp. 835-41.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*administration & dosage
Coinfection/*drug therapy
Hepatitis B/*drug therapy
Hepatitis B e Antigens/*blood
Hepatitis C/*drug therapy
Interferon-alpha/*administration & dosage
Lamivudine/*administration & dosage
Polyethylene Glycols/*administration & dosage
Ribavirin/*administration & dosage
Adult ; Biomarkers/blood ; Coinfection/diagnosis ; Coinfection/virology ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Hepatitis B/diagnosis ; Hepatitis B/virology ; Hepatitis C/diagnosis ; Hepatitis C/virology ; Humans ; Interferon alpha-2 ; Male ; Middle Aged ; Recombinant Proteins/administration & dosage ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication.
Autorzy:
Chou WW; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Tsai YS; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.
Hsieh MY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.
Huang CI; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Tsai PC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.
Hsi E; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Genome Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Juo SH; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Department of Genome Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Tsai WL; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Medicine, National Yang Ming University, Taipei, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Center for Infectious Disease and Cancer Research, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Center for Lipid Science and Aging Research, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Center for Infectious Disease and Cancer Research, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Center for Lipid Science and Aging Research, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan. .; Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. .; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. .; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. .; Center for Infectious Disease and Cancer Research, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. .; Center for Lipid Science and Aging Research, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. .; Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. .
Pokaż więcej
Źródło:
Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2016 Mar; Vol. 94 (3), pp. 311-20. Date of Electronic Publication: 2015 Oct 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*pharmacology
Hepacivirus/*drug effects
Hepatitis C/*drug therapy
Hepatitis C/*genetics
Interferon-alpha/*pharmacology
MicroRNAs/*genetics
Ribavirin/*pharmacology
Antiviral Agents/therapeutic use ; Cell Line ; Hepacivirus/genetics ; Hepacivirus/physiology ; Hepatitis C/blood ; Hepatitis C/virology ; Humans ; Interferon-alpha/therapeutic use ; Liver/metabolism ; Liver/pathology ; Liver/virology ; MAP Kinase Signaling System/drug effects ; MicroRNAs/blood ; Ribavirin/therapeutic use ; Up-Regulation/drug effects ; Viral Load/drug effects ; Virus Replication/drug effects
Czasopismo naukowe
Tytuł:
The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients.
Autorzy:
Huang JF; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Huang CI; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Tsai PC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Lin PC; Center for Teaching and Research, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen YL; Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Chang WT; Division of HBP Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hou NJ; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ZY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2015 Dec; Vol. 30 (12), pp. 1768-74.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Tertiary Prevention*
Antiviral Agents/*administration & dosage
Carcinoma, Hepatocellular/*etiology
Carcinoma, Hepatocellular/*prevention & control
Hepatitis C, Chronic/*complications
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*administration & dosage
Liver Neoplasms/*etiology
Liver Neoplasms/*prevention & control
Polyethylene Glycols/*administration & dosage
Ribavirin/*administration & dosage
Aged ; Biomarkers, Tumor/blood ; Carcinoma, Hepatocellular/diagnosis ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Histocompatibility Antigens Class I/blood ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnosis ; Predictive Value of Tests ; Prospective Studies ; Recombinant Proteins/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial.
Autorzy:
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Huang CF; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Occupational Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Dai CY; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Huang JF; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Lin JW; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Liang CC; Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan.
Yang SS; Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Lin CL; Department of Gastroenterology, Taipei City Hospital, Ren-Ai Branch, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Yang HC; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taiwan.
Chuang WL; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Yu ML; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2015 Oct 15; Vol. 5, pp. 15255. Date of Electronic Publication: 2015 Oct 15.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*therapeutic use
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Ribavirin/*therapeutic use
Adult ; Aged ; Body Weight ; Dose-Response Relationship, Drug ; Female ; Genotype ; Hepatitis C, Chronic/virology ; Humans ; Male ; Middle Aged ; RNA, Viral/analysis ; RNA, Viral/metabolism ; Recombinant Proteins/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study.
Autorzy:
Yeh ML; From the Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital (M-LYeh, M-YH, C-FH, P-CL, Y-HL, Z-YL, S-CC, J-FH, C-YD, W-LC, M-LYu), Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University (M-LYeh, C-FH, M-HH, Z-YL, S-CC, J-FH, C-YD, W-LC; M-LYu), Institute of Biomedical Sciences, National Sun Yat-Sen University (M-LYu), Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital (C-IH, N-JH), Department of Occupational Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University (C-FH), Department of Preventive Medicine, Kaohsiung Medical University Hospital (M-HH), Graduate Institute of Medicine, College of Medicine (M-LYeh, C-YD), Center for Infectious Disease and Cancer Research; and Center for Lipid Science and Aging Research, Kaohsiung Medical University, Kaohsiung, Taiwan (C-YD, W-LC, M-LYu).
Hsieh MY
Huang CI
Huang CF
Hsieh MH
Liang PC
Lin YH
Hou NJ
Lin ZY
Chen SC
Huang JF
Dai CY
Chuang WL
Yu ML
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2015 Oct; Vol. 94 (42), pp. e1837.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Precision Medicine*
Antiviral Agents/*therapeutic use
Hepatitis B, Chronic/*drug therapy
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Ribavirin/*administration & dosage
Drug Therapy, Combination ; Female ; Hepatitis B, Chronic/complications ; Hepatitis C, Chronic/complications ; Humans ; Interferon alpha-2 ; Male ; Middle Aged ; Recombinant Proteins/therapeutic use
Czasopismo naukowe
Tytuł:
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial.
Autorzy:
Liu CH; 1] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [2] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [3] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan [4] Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Huang CF; 1] Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan [2] Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan [3] Department of Occupational Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Liu CJ; 1] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [2] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [3] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Dai CY; 1] Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan [2] Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Huang JF; 1] Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan [2] Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Lin JW; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Liang CC; Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan.
Yang SS; Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Lin CL; Department of Gastroenterology, Taipei City Hospital, Ren-Ai Branch, Taipei, Taiwan.
Su TH; 1] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [2] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [3] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Yang HC; 1] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [2] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan [3] Department of Microbiology, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei.
Chen PJ; 1] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [2] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [3] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; 1] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [2] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [3] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan [4] Genomics Research Center, Academia Sinica, Taiwan.
Chuang WL; 1] Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan [2] Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Kao JH; 1] Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan [2] Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan [3] Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Yu ML; 1] Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan [2] Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan [3] Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2015 Jul 01; Vol. 5, pp. 11710. Date of Electronic Publication: 2015 Jul 01.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*therapeutic use
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Ribavirin/*therapeutic use
Adult ; Aged ; Drug Administration Schedule ; Female ; Genotype ; Hepatitis C, Chronic/genetics ; Hepatitis C, Chronic/pathology ; Humans ; Interferons ; Interleukins/genetics ; Interleukins/metabolism ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; RNA, Viral/analysis ; RNA, Viral/genetics ; Recombinant Proteins/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
Autorzy:
Yeh ML; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Peng CY; Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Dai CY; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lai HC; Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Huang CF; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Occupational Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MY; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Departmentof Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Departmentof Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ZY; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Division of Hepatobiliary, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Apr 02; Vol. 10 (4), pp. e0122259. Date of Electronic Publication: 2015 Apr 02 (Print Publication: 2015).
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*therapeutic use
DNA, Viral/*antagonists & inhibitors
Hepatitis B virus/*drug effects
Hepatitis B, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Adult ; Alanine Transaminase/blood ; Biomarkers/blood ; Creatinine/blood ; DNA, Viral/genetics ; Drug Administration Schedule ; Female ; Hepatitis B Surface Antigens/blood ; Hepatitis B e Antigens/blood ; Hepatitis B virus/genetics ; Hepatitis B virus/growth & development ; Hepatitis B, Chronic/blood ; Hepatitis B, Chronic/immunology ; Hepatitis B, Chronic/virology ; Humans ; Male ; Middle Aged ; Recombinant Proteins/therapeutic use ; Treatment Outcome ; Viral Load/drug effects
Czasopismo naukowe
Tytuł:
Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan.
Autorzy:
Yu ML; From the Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital (Ming-Lung Yu, Ming-Lun Yeh, P-CT, J-FH, C-FH, P-CL, Y-HL, M-YH, Z-YL, S-CC, C-YD, W-LC, W-YC); Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University (Ming-Lung Yu, J-FH, C-FH, M-HH, Z-YL, S-CC, C-YD, W-LC); Institute of Biomedical Sciences, National Sun Yat-Sen University (Ming-Lung Yu); Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University (C-IH, N-JH); Department of Occupational Medicine, Kaohsiung Municipal Ta-Tung Hospital (C-FH); Department of Preventive Medicine, Kaohsiung Medical University Hospital (M-HH); Department of Occupational Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University (W-YL); and Taiwan Liver Research Foundation, Kaohsiung, Taiwan (W-YC).
Yeh ML
Tsai PC
Huang CI
Huang JF
Huang CF
Hsieh MH
Liang PC
Lin YH
Hsieh MY
Lin WY
Hou NJ
Lin ZY
Chen SC
Dai CY
Chuang WL
Chang WY
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2015 Apr; Vol. 94 (13), pp. e690.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Medication Adherence*
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Ribavirin/*therapeutic use
Adult ; Aged ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; Female ; Health Knowledge, Attitudes, Practice ; Health Services Accessibility ; Hepatitis C, Chronic/epidemiology ; Hepatitis C, Chronic/therapy ; Humans ; Interferon alpha-2 ; Interferon-alpha/administration & dosage ; Interferon-alpha/adverse effects ; Male ; Middle Aged ; Polyethylene Glycols/administration & dosage ; Polyethylene Glycols/adverse effects ; Prevalence ; Prospective Studies ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/adverse effects ; Recombinant Proteins/therapeutic use ; Ribavirin/administration & dosage ; Ribavirin/adverse effects ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł:
A 24-week pegylated interferon alpha-2b versus a 12-week pegylated interferon alpha-2b alone or with ribavirin for patients with acute hepatitis C.
Autorzy:
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical UniversityHospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL
Yu ML
Pokaż więcej
Źródło:
Hepatology (Baltimore, Md.) [Hepatology] 2014 Dec; Vol. 60 (6), pp. 2128-9. Date of Electronic Publication: 2014 Sep 18.
Typ publikacji:
Letter; Comment
MeSH Terms:
Antiviral Agents/*administration & dosage
Hepatitis C/*drug therapy
Interferon-alpha/*administration & dosage
Polyethylene Glycols/*administration & dosage
Ribavirin/*administration & dosage
Female ; Humans ; Male
Opinia redakcyjna
Tytuł:
Variants of the inosine triphosphate pyrophosphatase gene and relapse risk following treatment for HCV genotype 2/3.
Autorzy:
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University HospitalM Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL
Yu ML
Pokaż więcej
Źródło:
Hepatology (Baltimore, Md.) [Hepatology] 2014 Dec; Vol. 60 (6), pp. 2129-30. Date of Electronic Publication: 2014 Sep 19.
Typ publikacji:
Letter; Comment
MeSH Terms:
Genetic Variation*
Antiviral Agents/*administration & dosage
Hepatitis C/*drug therapy
Hepatitis C/*genetics
Interferon-alpha/*administration & dosage
Polyethylene Glycols/*administration & dosage
Pyrophosphatases/*genetics
Ribavirin/*administration & dosage
Female ; Humans ; Male
Opinia redakcyjna
Tytuł:
Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection.
Autorzy:
Huang CI; Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Huang CF
Huang JF
Dai CY
Yeh ML
Hsieh MY
Lin ZY
Chen SC
Wang LY
Yu ML
Chuang WL
Pokaż więcej
Źródło:
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2014 May; Vol. 29 (5), pp. 1012-8.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*administration & dosage
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Hepatitis C, Chronic/*virology
Interferon-alpha/*administration & dosage
Polyethylene Glycols/*administration & dosage
Ribavirin/*administration & dosage
Adult ; Drug Therapy, Combination ; Female ; Genotype ; Humans ; Interferon alpha-2 ; Interferons ; Interleukins/genetics ; Logistic Models ; Male ; Middle Aged ; Recombinant Proteins/administration & dosage ; Treatment Outcome ; Viral Load
Czasopismo naukowe
Tytuł:
Pegylated interferon and ribavirin: a therapeutic option in patients who fail to respond to telaprevir-based triple therapy?
Autorzy:
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL
Yu ML
Pokaż więcej
Źródło:
Hepatology (Baltimore, Md.) [Hepatology] 2013 Oct; Vol. 58 (4), pp. 1519-20. Date of Electronic Publication: 2013 Aug 14.
Typ publikacji:
Letter; Comment
MeSH Terms:
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Oligopeptides/*therapeutic use
Polyethylene Glycols/*therapeutic use
Ribavirin/*therapeutic use
Humans ; Male
Opinia redakcyjna
Tytuł:
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.
Autorzy:
Huang JF; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML
Huang CF
Juo SH
Dai CY
Hsieh MY
Hou NJ
Yeh ML
Hsieh MH
Yang JF
Lin ZY
Chen SC
Shin SJ
Chuang WL
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2012 Jul; Vol. 32 (6), pp. 962-9. Date of Electronic Publication: 2012 Feb 22.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Prediabetic State/*complications
Ribavirin/*therapeutic use
Adult ; Aged ; Biomarkers/blood ; Blood Glucose/metabolism ; Chi-Square Distribution ; Drug Therapy, Combination ; Female ; Glycated Hemoglobin/metabolism ; Hepatitis C, Chronic/blood ; Hepatitis C, Chronic/complications ; Hepatitis C, Chronic/diagnosis ; Hepatitis C, Chronic/genetics ; Humans ; Interferon alpha-2 ; Interferons ; Interleukins/genetics ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Odds Ratio ; Polymorphism, Single Nucleotide ; Prediabetic State/blood ; Prediabetic State/genetics ; Prospective Studies ; Recombinant Proteins/therapeutic use ; Risk Assessment ; Risk Factors ; Taiwan ; Treatment Outcome ; Viral Load
Czasopismo naukowe
Tytuł:
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients.
Autorzy:
Hsieh MY; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Dai CY
Lee LP
Huang JF
Chuang WL
Hou NJ
Lin ZY
Chen SC
Hsieh MY
Wang LY
Chang WY
Yu ML
Pokaż więcej
Źródło:
The Kaohsiung journal of medical sciences [Kaohsiung J Med Sci] 2012 Feb; Vol. 28 (2), pp. 86-93. Date of Electronic Publication: 2012 Jan 20.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Antinuclear/*blood
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*blood
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Ribavirin/*therapeutic use
Adult ; Aged ; Female ; Humans ; Interferon alpha-2 ; Male ; Middle Aged ; Recombinant Proteins/therapeutic use ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies